Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
Why the amount of bacteriostatic water matters Reconstitution is not just about dissolving powder
Du fr en fleksibel nettside som kan vokse i takt med virksomheten din uten skjulte kostnader eller tekniske hindre
A 19-item CoEQ was administered at weeks 0, 20, 52, and 104 in a subgroup of participants
Keywords: anti-obesity medications, glp-1 receptor agonists, meta-analysis, orlistat, weight retention Introduction and background Obesity is a chronic, relapsing, and multifactorial disease, associated with increased morbidity, mortality, and healthcare burden globally [1]
